Peninsula biotech lands $150 million deal to tackle brain diseases

Alzheimer's disease and amyotrophic lateral sclerosis, or Lou Gehrig's disease, are two potential deals of a multi-year deal between a Peninsula company and Celgene.

Source: bizjournals.com Health Care:Biotechnology headlines - March 20, 2018 Category: Biotechnology Authors: Ron Leuty Source Type: news